A biopharmaceutical company with an FDA-approved medicine to treat sickle cell disease
Seeking support to help GBT develop and deliver life-changing treatments for people living with grievous blood-based disorders, starting with sickle cell disease.
HCR - Health Issues
196 - U.S. Agency for International Development (USAID)
BLUE STAR STRATEGIES LLC
888 17th Street NW, Suite 800, Washington, DC, 20006, US
SALLY PAINTER